NCT03457792View on ClinicalTrials.gov

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Rheumatoid Arthritis
Trial Locations (1)

79095

Local Institution, Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03457792 - A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter